J8502 — Injection, aprepitant (aponvie), 1 mg
J8502 is a HCPCS Level II code for injection, aprepitant (aponvie), 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.
Medicare coverage: Carrier judgment
Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
Physician fee schedule statusE
Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).
Global period: XXX
Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.
The CMS record for J8502
- Long descriptor
- Injection, aprepitant (aponvie), 1 mg
- Short descriptor
- Inj, aponvie, 1 mg
- Added
- April 1, 2026
- BETOS
- O1E
- Pricing indicator
- 51 — Other
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Drugs.
Codes adjacent to J8502
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J8502 is not quite right, the correct code is very often within a few positions of it.
- J7685Tobramycin, inhalation solution, compounded product, administered through dme, unit dose form, per 300 milligrams
- J7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mg
- J7699Noc drugs, inhalation solution administered through dme
- J7799Noc drugs, other than inhalation drugs, administered through dme
- J7999Compounded drug, not otherwise classified
- J8498Antiemetic drug, rectal/suppository, not otherwise specified
- J8499Prescription drug, oral, non chemotherapeutic, nos
- J8501Aprepitant, oral, 5 mg
- J8510Busulfan; oral, 2 mg
- J8515Cabergoline, oral, 0.25 mg
- J8520Capecitabine, oral, 150 mgterminated
- J8521Capecitabine, oral, 500 mgterminated
- J8522Capecitabine, oral, 50 mg
- J8530Cyclophosphamide; oral, 25 mg
- J8540Dexamethasone, oral, 0.25 mg
- J8541Dexamethasone (hemady), oral, 0.25 mg
Questions about J8502
What is HCPCS code J8502?
J8502 is a HCPCS Level II code for injection, aprepitant (aponvie), 1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J8502?
The CMS HCPCS file marks J8502 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.
How is J8502 paid under the physician fee schedule?
J8502 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).